Request Deal Involvement

Access Biotechnology led a $135m Series B round in Hemab.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

Schulte Roth & Zabel

legal advisors

Schulte Roth & Zabel

or

Principals

MAJ INVEST EQUITY A/S

bidder

MAJ INVEST EQUITY A/S

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

HEMAB

target

HEMAB

ACCESS BIOTECHNOLOGY

bidder

ACCESS BIOTECHNOLOGY

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

AVORO CAPITAL

bidder

AVORO CAPITAL

ROCK SPRINGS CAPITAL

bidder

ROCK SPRINGS CAPITAL

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

HEALTHCAP

bidder

HEALTHCAP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite